Menu Back toAgenda

1st Regional Conference on Regulatory Harmonisation


Agenda

Day 1

Day 2

Related events

  • Face-to-Face

    DIA EUROPE 2018

  • Face-to-Face

    Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets

    NEW OFFERING! This intermediate course will provide practical real-world, actionable information on the nature and development of global regulatory strategies for drug development, with a focus on markets located outside the US and Europe.

  • Face-to-Face

    Market Access and Health Technology Assessment (HTA): What Every Pharmaceutical Stakeholder Should Know

    Main objective of this course is to illustrate how pharmaceutical pricing and reimbursement policy is developing, how the use of HTA is evolving, and how companies should address these developments by developing and reinforcing their both their strategic and technical market access capabilities.

  • Face-to-Face

    Navigating CMC Requirements During Drug Development and Post-Approval

    This training will offer you the overview of the existing regulatory aspects of the CMC, and will also give you a proper understanding on how to face the challenges during the drug development and its post-approval.